Supplementary Table S1 from ESR1 Mutation in Endocrine Treatment-Naïve Endometrial Cancer: Prevalence, Characteristics, and Prognostic Implications, Results from the UTOLA Phase II GINECO Trial
Blanc-Durand F., Genestie C., Nikolaev S., Leman R., Church DN., Beinse G., Tredan O., Bengrine Lefevre L., Brachet P-E., Lebreton C., Meynard G., Fournel P., Frenel J-S., Selle F., Cornila C., Fernandez Diez Y., Bonnet E., Arnaud A., Kaczmarek E., Follana P., Hardy-Bessard A-C., Fabbro M., Cojean Zelek I., Roche S., Duliege D., Mouret-Reynier MA., Bouchaert P., Alexandre J., Joly F., Leary A.